ABK Biomedical
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
155 Chain Lake Dr Unit 32, Halifax, Nova...Phone Number
(902) 442-4009Website
www.abkbiomedical.comRevenue
$8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ABK Biomedical
ABK Biomedical is a company focused on researching, developing and commercializing medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. ABK Biomedical holds intellectual property in the areas of inorganic polymer microspheres and unique administration systems. The company possesses advanced intellectual capital and its own R&D and manufacturing facilities for developing and commercializing unique embolotherapy products. Eye90 microspheres® is considered an investigational product and is not approved for use in any regulatory jurisdiction outside of approved clinical trials.Explore more
ABK Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ABK Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ABK Biomedical has new funding data
Check if ABK Biomedical has recently received funding, and reach out quickly before it becomes old news!
Click to see if ABK Biomedical had a recent Job posting/layoffs
Product Launch: Get notified when ABK Biomedical launches new products
Website visits: Recent activity has been detected on your website
ABK Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ABK Biomedical
Earning: See what the market has to say on ABK Biomedical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ABK Biomedical is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ABK Biomedical
Compare insights from companies similar to ABK Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ABK Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ABK Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ABK Biomedical.
ABK Biomedical financials insights
Gather financial insights about ABK Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$9M
2019
Series B
$30M
2022
Series C
$30M
2025
Series D
$35M
ABK Biomedical Tech Stack
A closer look at the technologies used by ABK Biomedical
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Project
, according to a mid-level source in LGL, is in the midst of initiatives related to process automation.
Automation, Digital Technology
Project
, according to a mid-level source in LGL, is in the midst of initiatives related to document management systems. The organization is currently evaluating various vendors.
Document Management, Software
Funding
ABK Biomedical News & Media
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
Final Patient Treated in FDA IDE Study Evaluating Eye90 microspheres® for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) HALIFAX, NS, Feb. 24, 2026 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and...ABK Biomedical Raises US$35M in Series D Financing
/PRNewswire/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable...ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer
HALIFAX, NS, Nov. 19, 2024 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, has received FDA approval to advance its Investigational Drug Exemption (IDE)...ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
HALIFAX, NS, Oct. 24, 2023 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, today announced the first patient treated in its Route90 US IDE Pivotal study....
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ABK Biomedical
Sign Up For FreeTo access detailed company insights
ABK Biomedical is a company focused on researching, developing and commercializing medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. ABK Biomedical holds intellectual property in the areas of inorganic polymer microspheres and unique administration systems. The company p... Read More
